Skip to main content
Premium Trial:

Request an Annual Quote

CLC Bio, GenoLogics to Collaborate on Next-Gen Sequencing Informatics

NEW YORK (GenomeWeb News) – CLC Bio and GenoLogics will integrate their lab and data management systems specifically for use in handling data from next-generation sequencing research, CLC Bio said today.

The collaboration will involve integrating GenoLogics' Geneus lab and data management system and CLC Bio's Genomics Workbench and NGS Cell platforms, which the companies will market as a solution for analysis, tracking, data pipelining, and project and workflow management utilities.

CLC Bio said that the solution also offers a graphic interface for use in a range of genomics, transcriptomics, and epigenomics computing projects.

CLC Bio CEO Thomas Knudsen said in a statement that the integrated offering will enable researchers to "keep up with the vast volumes of sequencing data being churned out by high-throughput sequencing machines, and quickly turn the massive amounts of raw data into meaningful results."

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more